Histopathology of Hematoxylin and Eosin (H&E)-stained tissue obtained from biopsy is commonly used in prostate cancer (PCa) diagnosis. Automatic PCa classification of digitized H&E slides has been developed before, but no attempts have been made to classify PCa using additional tissue stains registered to H&E. In this paper, we demonstrate that using H&E, Ki67 and p63-stained (3-stain) tissue improves PCa classification relative to H&E alone. We also show that we can infer PCa-relevant Ki67 and p63 information from the H&E slides alone, and use it to achieve H&E-based PCa classification that is comparable to the 3-stain classification. Reported improvements apply to classifying benign vs. malignant tissue, and low grade (Gleason group 2) vs. high grade (Gleason groups 3,4,5) cancer. Specifically, we conducted four classification tasks using 333 tissue samples extracted from 231 radical prostatectomy patients: regression tree-based classification using either (i) 3-stain features, with a benign vs malignant area under the curve (AUC = 92.9%), or (ii) real H&E features and H&E features learned from Ki67 and p63 stains (AUC = 92.4%), as well as deep learning classification using either (iii) real 3-stain tissue patches (AUC = 94.3%) and (iv) real H&E patches and generated Ki67 and p63 patches (AUC = 93.0%) using a deep convolutional generative adversarial network. Classification performance was assessed with Monte Carlo cross validation and quantified in terms of the Area Under the Curve, Brier score, sensitivity, and specificity. Our results are interpretable and indicate that the standard H&E classification could be improved by mimicking other stain types.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2020.104053DOI Listing

Publication Analysis

Top Keywords

ki67 p63
16
pca classification
12
classification
10
h&e
10
prostate cancer
8
h&e slides
8
3-stain tissue
8
benign malignant
8
grade gleason
8
area curve
8

Similar Publications

Hyalinizing clear cell carcinoma (HCCC) is a rare, low-grade epithelial tumor predominantly found in the salivary glands, with tracheal involvement being particularly uncommon. The present study details a case of primary tracheal HCCC and its clinical presentation, diagnostic challenges and the therapeutic approach used. A 34-year-old female patient presented with a 1-month history of intermittent dyspnea.

View Article and Find Full Text PDF
Article Synopsis
  • A case of proliferative myositis (PM) of the breast is presented, marking only the second documented instance in English literature.
  • A 49-year-old woman developed a rapidly growing mass in her right breast after surgeries for other tumors, leading to initial concerns about malignancy; extensive immunohistochemical testing ultimately diagnosed PM.
  • The findings highlight the critical need to identify pseudomalignant conditions in order to prevent unnecessary aggressive treatments.
View Article and Find Full Text PDF

Background: Nephrogenic adenoma (NA) is a rare benign tumor that can develop at any site of the urinary system, with the bladder being the most common, followed by the urethra, ureters, renal pelvises, etc. Currently, it is unclear what the pathogenesis of NA is. This study discussed a rare case of malignant transformation from NA to mesonephric adenocarcinoma of the bladder.

View Article and Find Full Text PDF
Article Synopsis
  • Liposarcoma is a rare malignant tumor that can occur in the mediastinum, and most existing information comes from scattered reports rather than extensive studies.
  • A 51-year-old man presented with respiratory symptoms and was found to have a large mediastinal mass that was misidentified as a teratoma; after surgery, he was diagnosed with dedifferentiated liposarcoma.
  • Despite surgical intervention and chemotherapy, the patient experienced rapid recurrence and ultimately died four months post-surgery, highlighting the need for correct diagnosis and treatment strategies for this aggressive condition.*
View Article and Find Full Text PDF

Purpose: This study aimed to conduct a systematic review summarizing the clinicopathological, prognostic, and molecular features of salivary gland intraductal carcinoma (SGIC).

Methods: This study followed the PRISMA 2020 guidelines and was registered in the PROSPERO database. It included case reports, case series studies, and cohort studies of SGIC indexed in the PubMed, Web of Science, Scopus, and Embase databases published between 1983 and 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!